Delivery of Medicines for the Needs of 'KOC-Shumen' EOOD under Framework Agreement No. RD-11-393/12.09.2025

This tender concerns the supply of medicines for the needs of the Oncology Center - Shumen (KOC-Shumen) EOOD. The procurement is conducted under a framework agreement, identified by number RD-11-393/12.09.2025. The scope of the contract involves the delivery of various medicinal products required by the hospital to serve its patients. KOC-Shumen EOOD is a specialized medical facility focused on the diagnosis and treatment of cancer. The framework agreement structure suggests that multiple deliveries might be required over a specified period, with potential for repeat orders based on the established terms and conditions. Bidders are expected to demonstrate their capability to supply high-quality pharmaceuticals, adhere to strict delivery schedules, and comply with all relevant Bulgarian pharmaceutical regulations and standards. The tender aims to ensure a consistent and reliable supply of essential medicines to KOC-Shumen, thereby supporting its critical healthcare services. Further details regarding specific types and quantities of medicines, delivery locations, and contractual obligations are likely detailed within the full tender documentation associated with the framework agreement.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Bulgaria, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 61.7 million.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.